| ??? ?????? |
?????????? ? ? ?????????? ? ? 4-18-00-02431 (???? ???? ????????) ? 0070810 ?? ?? ?? 116787 ???? ????? ?????? ? (1beta ? 3beta ? 5beta) -3- ((6-Deoxy-3-O-methyl-alpha-L-talopyranosyl) oxy) -1?14-dihydroxycard-20 (22) -enolide ? 5-????-?????-20 (22)-??????? 3-????- ((6-??????-3-O-?????-????-L-?????????????) ?????) -1-????? 14-????? ????????-? ?????????? ? (8CI) ? ?????-20 (22) -?????? ? 3- ((6-??????-3-O-?????-????-L-?????????????) ?????) -1?14-????? ????????- ? (1beta?3beta?5beta)- (9CI) ? (1beta,3beta,5beta,8xi,9xi)-3-[(6-deoxy-3-O-methyl-beta-L-glycero-hexopyranosyl)oxy]-1,14-dihydroxycard-20(22)-enolide |
| ????? ???????? |
(1beta,3beta,5beta)-3- [(6-deoxy-3-O-methylhexopyranosyl)oxy]-1,14-dihydroxycard-20(22)-enolide |
| ????? ??????????? |
acovenoside A;Acovenoside A; 4-18-00-02431 (Beilstein Handbook Reference); BRN 0070810; NSC 116787; (1beta,3beta,5beta)-3-((6-Deoxy-3-O-methyl-alpha-L-talopyranosyl)oxy)-1,14-dihydroxycard-20(22)-enolide; 5-beta-Card-20(22)-enolide, 3-beta-((6-deoxy-3-O-methyl-alpha-L-talopyranosyl)oxy)-1-beta,14-dihydroxy-; Acovenoside A (8CI); Card-20(22)-enolide, 3-((6-deoxy-3-O-methyl-alpha-L-talopyranosyl)oxy)-1,14-dihydroxy-, (1beta,3beta,5beta)- (9CI); (1beta,3beta,5beta,8xi,9xi)-3-[(6-deoxy-3-O-methyl-beta-L-glycero-hexopyranosyl)oxy]-1,14-dihydroxycard-20(22)-enolide; (1beta,3beta,5beta)-3-[(6-deoxy-3-O-methylhexopyranosyl)oxy]-1,14-dihydroxycard-20(22)-enolide |
| ?????? ???????? |
C30H46O9 |
| ????? ??????? ??????? |
550.6808 |
| InChI |
InChI=1/C30H46O9/c1-15-24(33)26(36-4)25(34)27(38-15)39-18-12-17-5-6-21-20(29(17,3)22(31)13-18)7-9-28(2)19(8-10-30(21,28)35)16-11-23(32)37-14-16/h11,15,17-22,24-27,31,33-35H,5-10,12-14H2,1-4H3/t15?,17-,18-,19-,20+,21-,22-,24?,25?,26?,27?,28-,29+,30+/m1/s1 |
| ?????????? ???????? ??????? |
663-95-6 |
| ???????? ????????? ??? |
211-555-5 |
| ???? ?????? |
|
| ????? |
1.31g/cm3 |
| ???? ??????? |
734.3°C at 760 mmHg |
| ????? ???????? |
1.592 |
| ???? ?????? |
236.4°C |
| ??? ?????? |
6.81E-25mmHg at 25°C |
|